Skip to main content

Developments in mergers and acquisitions in the healthcare and life sciences sector

Life Sciences & Healthcare M&A Research 2024

In a dynamic and ever-changing market environment, understanding mergers and acquisitions (M&A) is crucial for the future of the healthcare and life sciences sector. Deloitte's annual M&A research provides an in-depth analysis of trends and developments within the Dutch healthcare and life sciences market. This Dutch report, now available for download, is based on 2024 data and offers valuable insights to assist you in strategic decision-making and identifying opportunities in the sector.

Download the report here (Dutch)
1 MB PDF

Research Highlights

 

  • Decline in Transactions: In 2024, there were 104 acquisitions of healthcare companies with a revenue or enterprise value of at least €5 million, representing a drop of over 20% compared to previous years.
  • Role of Private Equity: Private equity-driven transactions fell by 38%, partly due to an unfavorable social and political climate, and uncertainty about new regulations.
  • Consolidation Trend: Despite the decrease in the number of transactions, consolidation continues in healthcare, with an increasing concentration in independent treatment centers (ZBCs)
  • Future Expectations: With more regulatory clarity and ongoing opportunities due to aging populations and staff shortages, Deloitte expects a recovery of activity in 2025.

Discover essential insights for strategic decision-making


This report offers a detailed overview of M&A activity within healthcare and life sciences, along with strategic insights relevant to stakeholders in the sector. The information in this report can help you as an investor, healthcare provider, policymaker, or consultant adjust your strategies to current market conditions and capitalize on future opportunities.

Download the report now to access valuable insights that can help you navigate the challenges and opportunities in the healthcare and life sciences sector. Please note that the report is in Dutch.

This research has also been published in the Financieele Dagblad (FD). For more information, you can read the article here.

Get in touch

Iris van Weel

​​Director​
+31882861784

Neil Lomax

Partner | Strategy, Risk & Transactions Advisory
+31611363917

Did you find this useful?

Yes
No

Thanks for your feedback

Your feedback is important to us

To tell us what you think, please update your settings to accept analytics and performance cookies.

Need help updating cookies?

Onze visie

Real Estate Predictions | Deloitte

From the transformative potential of GenAI and immersive technology to the emergence of sustainable smart buildings. Deloitte's real estate predictions, developed by Deloitte Netherlands, is an inspiring outlook for 2024 and beyond, based on the latest real estate insights. Our predictions will help you to future-proof your real estate business. Curious to learn what's next?
Perspective
5 minute read

M&A deals in the transport & logistics industry

Deloitte conducted an analysis on the transport & logistics M&A industry. The very positive M&A momentum is demonstrated by the strong recovery in terms of number of transactions after the COVID-19 outbreak.
Perspective

Why scaling AI is a prerequisite for success

Under the name ReplicAId, Deloitte and the Leiden University Medical Centre (LUMC) aim to collaborate with market parties to achieve rapid and targeted scaling of AI initiatives being developed in hospitals. The foundational belief is that AI is essential to addressing the biggest challenges in healthcare, and that scaling these initiatives is the only way to make AI profitable and truly labor-saving.
Perspective
4 minute read

Dutch M&A Predictions 2025 | Deloitte

Discover Deloitte's Dutch M&A Predictions 2025 for an insightful look at the Dutch market. Delve into key trends in mergers and acquisitions, including the transformative impact of AI, the growing importance of ESG frameworks, and how shifts in interest rates are shaping the M&A landscape.
Research

Let's connect

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited (“DTTL”), its global network of member firms, and their related entities (collectively, the “Deloitte organization”). DTTL (also referred to as “Deloitte Global”) and each of its member firms and related entities are legally separate and independent entities, which cannot obligate or bind each other in respect of third parties. DTTL and each DTTL member firm and related entity is liable only for its own acts and omissions, and not those of each other. DTTL does not provide services to clients. Please see www.deloitte.com/about to learn more. 

In The Netherlands the services are provided by independent subsidiaries or affiliates of Deloitte Holding B.V., an entity which is registered with the trade register in The Netherlands under number 40346342.

© 2025. For information, contact Deloitte Global.